Emergency Use Authorization Versus Full Approval of a Vaccine

Former FDA Commissioner Scott Gottlieb, MD joins us to review the mistakes, misrepresentations, and institutional barriers at the CDC and other public health institutions that hindered our response to the COVID-19 pandemic - along with the tactical steps we must take to defeat the next pandemic. We also discuss reforming the FDA approval process to allow medical innovation and why the drug price controls found in the Democrats' HR3 legislation will stop the next breakthrough drugs from emerging.

Scott Gottlieb, MD, is the author of "Uncontrolled Spread: Why COVID-19 Crushed Us and How We Can Defeat the Next Pandemic." He is a resident fellow at the American Enterprise Institute. From 2017 to 2019 he served as the 23rd commissioner of the Food and Drug Administration. Dr. Gottlieb is also a special partner with the venture capital firm New Enterprise Associates and serves on the boards of Pfizer, Illumina, Aetion, and Tempus. Follow him on Twitter at @ScottGottliebMD.